Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
Authors:
- Jianxin YangJYJianxin Yang
- Margit L MacDougallMMMargit L MacDougall
- Michael T McDowellMMMichael T McDowell
- Li XiLXLi Xi
- Ru WeiRWRu Wei
- William J ZavadoskiWZWilliam J Zavadoski
- Mark P MolloyMMMark P Molloy
- John D BakerJBJohn D Baker
- Max KuhnMKMax Kuhn
- Over CabreraOCOver Cabrera
- Judith L TreadwayJTJudith L Treadway
Open Access
- 1 June 2011
- journal article
- Published by Springer Nature in BMC Genomics
- Vol. 12 (1) , 281
Abstract
Glucagon is an important hormone in the regulation of glucose homeostasis, particularly in the maintenance of euglycemia and prevention of hypoglycemia. In type 2 Diabetes Mellitus (T2DM), glucagon levels are elevated in both the fasted and postprandial states, which contributes to inappropriate hyperglycemia through excessive hepatic glucose production. Efforts to discover and evaluate glucagon receptor antagonists for the treatment of T2DM have been ongoing for approximately two decades, with the challenge being to identify an agent with appropriate pharmaceutical properties and efficacy relative to potential side effects. We sought to determine the hepatic & systemic consequence of full glucagon receptor antagonism through the study of the glucagon receptor knock-out mouse (Gcgr-/-) compared to wild-type littermates.Keywords
This publication has 27 references indexed in Scilit:
- High-Throughput and Multiplexed LC/MS/MRM Method for Targeted MetabolomicsAnalytical Chemistry, 2010
- Bile acid-activated receptors in the treatment of dyslipidemia and related disordersProgress in Lipid Research, 2010
- Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and HyperglucagonemiaThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Role of Bile Acids and Bile Acid Receptors in Metabolic RegulationPhysiological Reviews, 2009
- The Glucagon Receptor Is Required for the Adaptive Metabolic Response to FastingCell Metabolism, 2008
- iTRAQ Experimental Design for Plasma Biomarker DiscoveryJournal of Proteome Research, 2008
- Transcriptional Regulation of MetabolismPhysiological Reviews, 2006
- PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBPOncogene, 2005
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverJournal of Clinical Investigation, 2002